August 20, 2008 - The BSD-2000/3D/MR, an imaging system that uses MR-tomography, produces high quality thermal imaging of cancer treatments in progress, even when interfering frequencies are introduced, reported two case studies published in the current issue of the International Journal of Hyperthermia (Vol. 4, pp. 327-335).

The results of these studies are significant in showing the versatility of the BSD-2000/3D/MR (BSD Medical's system used in the treatment of cancer) and how detection and elimination of spurious frequencies can be accomplished, even in adverse environments.

The BSD-2000/3D/MR is a hybrid integration of a BSD-2000/3D cancer treatment system with a magnetic resonance imaging system (MRI) used to visually monitor deep thermal therapy cancer treatments in progress with thermal imaging through MR-tomography. The images are in color and temperature within the images is differentiated visually by use of color coding. MR-tomography is therefore a classical application for
monitoring cancer treatments with BSD Medical's systems, as these treatments involve delivery of precision-focused heat through RF/microwave energy. The BSD-2000/3D/MR system integration was completed through the cooperative efforts of BSD Medical Corp. and Siemens Medical Systems.

These case studies showed that even when additional frequencies are added, that would otherwise produce imaging artifacts, they can be detected and eliminated in the system.

The BSD-2000/3D/MR is part of the family of BSD-2000 systems that are recipient of the Frost and Sullivan Innovation of the Year Award for cancer therapy devices.

For more information: www.BSDMedical.com


Additional Content

News | Radiology Imaging

Nov. 2, 2026 — Neurophet and RapidAI have partnered to integrate Neurophet’s advanced neurodegenerative brain imaging ...

Time November 04, 2026
arrow
News | Women's Health

Oct. 29, 2026 — Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive ...

Time October 30, 2026
arrow
News | Radiology Imaging

Oct. 19, 2026 — Paradromics Inc. has announced a collaboration with Siemens Healthineers to develop an advanced ...

Time October 26, 2026
arrow
News | Lung Imaging

Oct. 20, 2026 — Optellum has announced that its Virtual Nodule Clinic (VNC) with Lung Cancer Prediction (LCP) AI is ...

Time October 21, 2026
arrow
News | FDA

Oct.7, 2026 – MRI2CT Inc. has received FDA 510(k) clearance for NextMR, its AI powered imaging platform, for generating ...

Time October 07, 2026
arrow
Subscribe Now